![]() |
市場調查報告書
商品編碼
2071383
超低溫冷凍庫市場商機、成長要素、產業趨勢分析及2026-2035年預測。Ultra-low Temperature Freezers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
全球超低溫冷凍庫市場預計到 2025 年將達到 8.134 億美元,年複合成長率為 6.3%,到 2035 年將達到 15 億美元。

市場擴張的促進因素包括:對生物銀行和低溫保存解決方案日益成長的需求、疫苗儲存要求的不斷提高,以及製藥和生物技術領域研究活動的快速發展。對溫度敏感型生物製藥的日益依賴、臨床試驗的擴展以及個人化醫療的普及也在重塑著這一行業,所有這些都需要高度可控的儲存環境。此外,生命科學領域對可重複研究結果的需求以及嚴格的監管合規性也推動了市場需求。生技藥品和再生醫學領域的持續創新也增加了對穩定低溫運輸基礎設施的需求。隨著全球研發投入的增加,預計在預測期內,對節能高效、大容量低溫儲存系統的需求將顯著成長。
| 市場範圍 | |
|---|---|
| 開始年份 | 2025 |
| 預測期 | 2026-2035 |
| 上市時的市場規模 | 8.134億美元 |
| 預計金額 | 15億美元 |
| 複合年成長率 | 6.3% |
超低溫冷凍庫是一種專門設計的冷凍系統,用於維持極低的溫度,通常在-40 度C至-150 度C範圍內,以長期儲存敏感的生物和藥物樣本。這些系統廣泛用於保存DNA、RNA、蛋白質、疫苗和其他需要嚴格溫度穩定性的關鍵研究樣本。超低溫冷凍庫的運作通常在-40 度C至-86 度C範圍內,在確保生物樣本庫、實驗室和製藥設施中的檢體完整性方面發揮著至關重要的作用。臨床研究的活性化和個人化醫療的不斷擴展顯著增加了對可靠的低溫儲存系統的需求。此外,生物製藥公司需要嚴格的溫度控制環境來維持產品品質並符合相關法規。生物檢體長期儲存日益重要,加上再生醫學和生技藥品開發的進步,持續推動這些系統在全球研發和醫療基礎設施的應用。
到2025年,立式冷凍庫櫃將佔據54.2%的市場。該細分市場憑藉其節省空間的垂直設計以及在實驗室和醫療環境中易於操作等優勢,保持著主導地位。製藥公司、研究機構和生物樣本庫廣泛使用立式冷凍櫃,以實現樣本有序的儲存和快速取用。疫苗儲存、基因組研究以及臨床試驗中樣本保存需求的不斷成長,進一步推動了對這類系統的需求。
預計到2025年,醫藥和疫苗領域將佔據34.9%的市場。由於生技藥品、先進療法和溫度敏感型疫苗對儲存條件要求嚴格,該領域仍然是超低溫冷凍庫市場的主要驅動力。製藥公司、研究機構和分銷網路依賴這些系統來維持產品在整個儲存和運輸過程中的穩定性和有效性。生技藥品製劑開發平臺的擴展和全球免疫接種工作的推進,持續支撐著市場對超低溫冰箱的穩定需求。
到2025年,北美超低溫冷凍庫市佔率將達到42.1%。該地區正經歷強勁成長,這主要得益於生物銀行和冷凍保存業務的擴張。遍布北美的生物樣本庫網路高度依賴先進的冷凍保存系統,以長期保存用於研究和臨床的生物樣本。這些機構優先採用可靠且穩定的冷凍技術,以確保樣本的品質和完整性。
The Global Ultra-Low Temperature Freezers Market was valued at USD 813.4 million in 2025 and is estimated to grow at a CAGR of 6.3% to reach USD 1.5 billion by 2035.

Market expansion is driven by rising demand for biobanking and cryopreservation solutions, ongoing advancements in vaccine storage requirements, and the rapid growth of pharmaceutical and biotechnology research activities. The industry is also being shaped by the increasing reliance on temperature-sensitive biologics, clinical trial expansion, and the growing adoption of personalized medicine, all of which require highly controlled storage environments. Demand is further reinforced by the need for reproducible research outcomes and strict regulatory compliance across life sciences sectors. Continuous innovation in biologics and regenerative medicine is also intensifying the requirement for stable cold-chain infrastructure. As global R&D investments rise, the need for energy-efficient, high-capacity ultra-low temperature storage systems is expected to strengthen significantly over the forecast period.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $813.4 Million |
| Forecast Value | $1.5 Billion |
| CAGR | 6.3% |
Ultra-low temperature freezers are specialized refrigeration systems engineered to maintain extremely low temperatures, typically ranging from -40°C to -150°C, for the long-term preservation of sensitive biological materials and pharmaceutical samples. These systems are widely used to store DNA, RNA, proteins, vaccines, and other critical research specimens that require strict thermal stability. ULT freezers, generally operating between -40°C and -86°C, play a vital role in ensuring sample integrity across biobanks, laboratories, and pharmaceutical facilities. Rising clinical research activities and expanding personalized medicine applications have significantly increased the need for reliable cold storage systems. In addition, biopharmaceutical organizations require strict temperature-controlled environments to maintain product quality and regulatory compliance. The growing emphasis on long-term biological sample archiving, combined with advancements in regenerative medicine and biologics development, continues to support widespread adoption of these systems across global research and healthcare infrastructure.
The upright freezers segment accounted for 54.2% share in 2025. This segment maintains its leading position due to its space-efficient vertical design and ease of operation in laboratory and healthcare environments. Upright configurations are widely used in pharmaceutical companies, research institutions, and biobanks because they enable organized storage and quick access to samples. Growing requirements for sample preservation in vaccine storage, genomic research, and clinical trials continue to strengthen demand for these systems.
The pharmaceuticals and vaccines segment held a share of 34.9% in 2025. This segment remains a key driver of the ultra-low temperature freezers market due to strict storage requirements for biologics, advanced therapies, and temperature-sensitive vaccines. Pharmaceutical manufacturers, research organizations, and distribution networks rely on these systems to maintain product stability and efficacy throughout storage and transportation. Expanding biologic drug development pipelines and global immunization initiatives continue to support steady demand.
North America Ultra-Low Temperature Freezers Market accounted for 42.1% share in 2025. The region is witnessing strong growth supported by expanding biobanking and cryopreservation activities. A well-developed network of biobanks across North America depends heavily on advanced ultra-low temperature storage systems to preserve biological specimens for long-term research and clinical use. These facilities prioritize highly reliable and consistent freezing technologies to maintain sample quality and integrity.
Prominent players operating in the global ultra-low temperature freezers industry include:
Arctiko A/S, Avantor (VWR), B Medical Systems, Eppendorf AG, Esco Lifesciences, Froilabo, Haier Biomedical, Helmer Scientific, Labcold Ltd., NuAire Inc., PHC Holdings Corporation, So-Low Environmental Equipment, Stirling Ultracold, Thermo Fisher Scientific, Zhongke Meiling Cryogenics. Companies in the ultra-low temperature freezers market are strengthening their position through continuous product innovation focused on energy efficiency, temperature precision, and improved sample security features. Many manufacturers are investing in advanced compressor technologies, eco-friendly refrigerants, and enhanced insulation systems to reduce operational costs and improve sustainability. Strategic collaborations with pharmaceutical firms, research institutes, and healthcare providers are enabling customized solutions for specialized storage needs. Firms are also expanding their global distribution networks and after-sales service capabilities to improve customer retention. Integration of IoT-based monitoring systems, remote diagnostics, and predictive maintenance tools is further enhancing product reliability.